Patterns and correlates of PrEP drug detection among MSM and transgender women in the global iPrEx study

Copyright © 2014 by Lippincott Williams & Wilkins. Background: Adherence to pre-exposure prophylaxis (PrEP) is critical for efficacy. Antiretroviral concentrations are an objective measure of PrEP use and correlate with efficacy. Understanding patterns and correlates of drug detection can iden...

Full description

Saved in:
Bibliographic Details
Main Authors: Albert Liu, David V. Glidden, Peter L. Anderson, K. Rivet Amico, Vanessa McMahan, Megha Mehrotra, Javier R. Lama, John MacRae, Juan Carlos Hinojosa, Orlando Montoya, Valdilea G. Veloso, Mauro Schechter, Esper G. Kallas, Suwat Chariyalerstak, Linda Gail Bekker, Kenneth Mayer, Susan Buchbinder, Robert Grant
Format: Journal
Published: 2018
Online Access:https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=84925555523&origin=inward
http://cmuir.cmu.ac.th/jspui/handle/6653943832/45826
Tags: Add Tag
No Tags, Be the first to tag this record!
Institution: Chiang Mai University
id th-cmuir.6653943832-45826
record_format dspace
spelling th-cmuir.6653943832-458262018-01-24T06:18:11Z Patterns and correlates of PrEP drug detection among MSM and transgender women in the global iPrEx study Albert Liu David V. Glidden Peter L. Anderson K. Rivet Amico Vanessa McMahan Megha Mehrotra Javier R. Lama John MacRae Juan Carlos Hinojosa Orlando Montoya Valdilea G. Veloso Mauro Schechter Esper G. Kallas Suwat Chariyalerstak Linda Gail Bekker Kenneth Mayer Susan Buchbinder Robert Grant Copyright © 2014 by Lippincott Williams & Wilkins. Background: Adherence to pre-exposure prophylaxis (PrEP) is critical for efficacy. Antiretroviral concentrations are an objective measure of PrEP use and correlate with efficacy. Understanding patterns and correlates of drug detection can identify populations at risk for non-adherence and inform design of PrEP adherence interventions. Methods: Blood antiretroviral concentrations were assessed among active arm participants in iPrEx, a randomized placebo-controlled trial of emtricitabine/tenofovir in men who have sex with men and transgender women in 6 countries. We evaluated rates and correlates of drug detection among a random sample of 470 participants at week 8 and a longitudinal cohort of 303 participants through 72 weeks of follow-up. Results: Overall, 55% of participants (95% confidence interval: 49 to 60) tested at week 8 had drug detected. Drug detection was associated with older age and varied by study site. In longitudinal analysis, 31% never had drug detected, 30% always had drug detected, and 39% had an inconsistent pattern. Overall detection rates declined over time. Drug detection at some or all visits was associated with older age, indices of sexual risk, including condomless receptive anal sex, and responding "don't know" to a question about belief of PrEP efficacy (0-10 scale). Conclusions: Distinct patterns of study product use were identified, with a significant proportion demonstrating no drug detection at any visit. Research literacy may explain greater drug detection among populations having greater research experience, such as older men who have sex with men in the United States. Greater drug detection among those reporting highest risk sexual practices is expected to increase the impact and cost-effectiveness of PrEP. 2018-01-24T06:18:11Z 2018-01-24T06:18:11Z 2014-01-01 Journal 10779450 15254135 2-s2.0-84925555523 10.1097/QAI.0000000000000351 https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=84925555523&origin=inward http://cmuir.cmu.ac.th/jspui/handle/6653943832/45826
institution Chiang Mai University
building Chiang Mai University Library
country Thailand
collection CMU Intellectual Repository
description Copyright © 2014 by Lippincott Williams & Wilkins. Background: Adherence to pre-exposure prophylaxis (PrEP) is critical for efficacy. Antiretroviral concentrations are an objective measure of PrEP use and correlate with efficacy. Understanding patterns and correlates of drug detection can identify populations at risk for non-adherence and inform design of PrEP adherence interventions. Methods: Blood antiretroviral concentrations were assessed among active arm participants in iPrEx, a randomized placebo-controlled trial of emtricitabine/tenofovir in men who have sex with men and transgender women in 6 countries. We evaluated rates and correlates of drug detection among a random sample of 470 participants at week 8 and a longitudinal cohort of 303 participants through 72 weeks of follow-up. Results: Overall, 55% of participants (95% confidence interval: 49 to 60) tested at week 8 had drug detected. Drug detection was associated with older age and varied by study site. In longitudinal analysis, 31% never had drug detected, 30% always had drug detected, and 39% had an inconsistent pattern. Overall detection rates declined over time. Drug detection at some or all visits was associated with older age, indices of sexual risk, including condomless receptive anal sex, and responding "don't know" to a question about belief of PrEP efficacy (0-10 scale). Conclusions: Distinct patterns of study product use were identified, with a significant proportion demonstrating no drug detection at any visit. Research literacy may explain greater drug detection among populations having greater research experience, such as older men who have sex with men in the United States. Greater drug detection among those reporting highest risk sexual practices is expected to increase the impact and cost-effectiveness of PrEP.
format Journal
author Albert Liu
David V. Glidden
Peter L. Anderson
K. Rivet Amico
Vanessa McMahan
Megha Mehrotra
Javier R. Lama
John MacRae
Juan Carlos Hinojosa
Orlando Montoya
Valdilea G. Veloso
Mauro Schechter
Esper G. Kallas
Suwat Chariyalerstak
Linda Gail Bekker
Kenneth Mayer
Susan Buchbinder
Robert Grant
spellingShingle Albert Liu
David V. Glidden
Peter L. Anderson
K. Rivet Amico
Vanessa McMahan
Megha Mehrotra
Javier R. Lama
John MacRae
Juan Carlos Hinojosa
Orlando Montoya
Valdilea G. Veloso
Mauro Schechter
Esper G. Kallas
Suwat Chariyalerstak
Linda Gail Bekker
Kenneth Mayer
Susan Buchbinder
Robert Grant
Patterns and correlates of PrEP drug detection among MSM and transgender women in the global iPrEx study
author_facet Albert Liu
David V. Glidden
Peter L. Anderson
K. Rivet Amico
Vanessa McMahan
Megha Mehrotra
Javier R. Lama
John MacRae
Juan Carlos Hinojosa
Orlando Montoya
Valdilea G. Veloso
Mauro Schechter
Esper G. Kallas
Suwat Chariyalerstak
Linda Gail Bekker
Kenneth Mayer
Susan Buchbinder
Robert Grant
author_sort Albert Liu
title Patterns and correlates of PrEP drug detection among MSM and transgender women in the global iPrEx study
title_short Patterns and correlates of PrEP drug detection among MSM and transgender women in the global iPrEx study
title_full Patterns and correlates of PrEP drug detection among MSM and transgender women in the global iPrEx study
title_fullStr Patterns and correlates of PrEP drug detection among MSM and transgender women in the global iPrEx study
title_full_unstemmed Patterns and correlates of PrEP drug detection among MSM and transgender women in the global iPrEx study
title_sort patterns and correlates of prep drug detection among msm and transgender women in the global iprex study
publishDate 2018
url https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=84925555523&origin=inward
http://cmuir.cmu.ac.th/jspui/handle/6653943832/45826
_version_ 1681422817513439232